The Pathogenesis of Cutaneous Lupus Erythematosus Revealed through the Therapeutic Effects of Hydroxychloroquine | Chapter 12 | Advancement and New Understanding in Medical Science Vol. 6

In recent years of research in immunology, the understanding of innate immunity has deepened, and the concept of innate immunity has been proposed even in the field of acquired immunity. The conventional immunosuppressive treatments mainly act via regulation of acquired immunity. However, the involvement of innate immunity was confirmed for hydroxychloroquine (HCQ), which has been confirmed to be effective in the treatment of cutaneous lupus erythematosus (CLE). Approximately 1.5 years prior to this trial, HCQ was officially approved for use in Japan by the Japanese Ministry of Health, Labor and Welfare for the treatment of CLE and SLE in September 2015. This review introduces the mechanism underlying the development of CLE from the viewpoint of autoantibodies, cytokines, and innate immunity. Furthermore, the mechanism of action of HCQ is introduced and discussed.

Author(s) Details:

Fukumi Furukawa,
Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, 641-8509 Wakayama, Japan.

Please see the link here: https://stm.bookpi.org/ANUMS-V6/article/view/13363

Effective Treatments for Japanese Patients' Skin Lesions Associated with Discoid Lupus Erythematosus | Chapter 6 | Advanced Concepts in Pharmaceutical Research Vol. 3

 This branch aims to discuss about Effective Situations for Japanese Sufferers' Skin Lesions Associated with Discoid lupus erythematosus (DLE). DLE is an instigative skin disease that can occur in subjects with or outside systemic lupus erythematosus (SLE). Localized DLE, statement/widespread DLE, hypertrophic/ verrucous DLE, and mucosal DLE are all dispassionate characteristics. There are current and systemic therapies convenient. Corticosteroids and calcineurin inhibitors are examples of local treatments.  Antimalarials are widely accepted as first-line fundamental therapy around the planet. Dapsone and/or retinoids can also be advantageous if the positive and negative effects are cautiously considered. It is detracting to understand and explore the procedures of skin eruption development appropriating various methods such as mouse models so that find better treatments.This publication interprets the characteristics of DLE, allure pathogenesis, diagnostics, and current and novel targeted analysis. A PubMed and Cochrane Database of Systemic Reviews article search was conducted, and ultimate relevant references were deliberate. DLE treatment surrounds both topical and intrinsic treatments. Professional application of local corticosteroids and calcineurin inhibitors is considered first-line healing. When topical treatments are useless, antimalarials are accepted as a first-line systemic analysis.  An immunosuppressive or immunomodulator may be additional if the antimalarial treatment program is insufficient. Few novel promising medicines have existed evaluated or proven in patients who have enhance resistant to miscellaneous combinations of antimalarials and immunosuppressives/immunomodulators.

Author(s) Details:

Fukumi Furukawa,
Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, 641-8509 Wakayama, Japan.

Please see the link here: https://stm.bookpi.org/ACPR-V3/article/view/12699